Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has active ingredient |
False |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 200mg/5ml (4%) solution for injection ampoules |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacain Sintetica 40mg/ml (4%) solution for injection ampoules (Imported (Switzerland)) |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacaine 200mg/5ml (4%) solution for injection ampoules 10 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|
Bupivacain Sintetica 40mg/ml (4%) solution for injection ampoules (Imported (Switzerland)) 10 ampoule |
Has specific active ingredient |
True |
Bupivacaine hydrochloride anhydrous |
Inferred relationship |
Existential restriction modifier |
|